GlassScriptPhysician profile
Glen A Franklin
NPI 1124098462
$1,348.44
in general payments reported to CMS, 2019-2025
10 companies · $638 in 2025
The $638 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.17 · 2021: $107 · 2022: $220 · 2023: $202 · 2024: $106 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.19 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $647.47 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Smith+Nephew, INC. | $207.12 | 2021-2023 | Grafix Pl, Stravix, Oasis |
| Integra Lifesciences Corporation | $140.98 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Intuitive Surgical, INC. | $140.41 | 2022 | |
| Polynovo North America LLC | $107.58 | 2019-2023 | |
| Csl Behring | $35.10 | 2022-2024 | Kcentra |
| Boston Scientific Corporation | $20.14 | 2021 | |
| Polymedics Innovations INC. | $18.99 | 2024 | |
| Zimmer Biomet Holdings, INC. | $17.89 | 2024 | Ribfix Blu Advantage |
| Davol INC. | $12.76 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.